MillerKnoll (MLKN) news
Recent news
Biocon's Shaw: Biosimilars a very attractive segment
Biocon, India’s largest biopharmaceutical company, has positioned itself as a key player in the global biosimilars market, with its chairman and managing director, Kiran Mazumdar-Shaw, emphasizing the segment’s growing potential. The company recently received approval for its Glargine biosimilar in…
AInvest Wire · 10h agoMillerknoll raised to buy at Stonex, PT $30
AInvest Wire · 7d agoMillerknoll Inc says received about $10 mln net tariff refunds benefit in Q1
In its first-quarter fiscal 2026 earnings report, MillerKnoll Inc. disclosed that it received approximately $10 million in net tariff refunds during the period. This financial benefit contributed to the company’s overall performance and was highlighted as a notable factor in its quarterly results.…
AInvest Wire · Sep 22, 2026Millerknoll - Outlook FY capital expenditures $125 million to $135 million
AInvest Wire · Sep 22, 2026Millerknoll outlook Q2 adjusted EPS USD 0.43-0.49
AInvest Wire · Sep 22, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.